Olynth 1 mg/ml nasal spray

Olynth is a widely recognized brand of nasal decongestants containing the active ingredient xylometazoline. It is specifically formulated to provide relief from nasal congestion associated with the common cold, hay fever, or allergic rhinitis by narrowing the blood vessels in the nasal passages.

Originally a pharmacy brand from Germany, Olynth was developed under the pharmaceutical giant Johnson & Johnson. However, as part of a major corporate restructuring in 2023, Johnson & Johnson spun off its consumer health division into a separate, independent company called Kenvue. This transition included the transfer of global brands like Listerine, Neutrogena, and Olynth to the new entity.

Manufacturing for Olynth occurs across multiple European sites to supply various regional markets, including prominent facilities in France and Germany. Today, Kenvue operates as the ultimate owner, focusing exclusively on consumer health products and maintaining a significant global footprint from its headquarters in the United States.